Status:
UNKNOWN
Complications and Adverse Events in Lymphadenectomy in the Inguinal Area
Lead Sponsor:
University of Southern California
Conditions:
Consensus Development
Eligibility:
All Genders
18+ years
Brief Summary
The investigators aim to create an effective and accurate method to report, define, and classify complications and adverse events during and after Inguinal lymph node dissection (ILND) as part of the ...
Detailed Description
Inguinal lymph node dissection (ILND) has shown to be a necessary surgery from the oncology standpoint being extensively used as part of the staging process in malignancies of the penis, vulva, or mel...
Eligibility Criteria
Inclusion
- Experts in open inguinal lymphadenectomy
- Experts in video endoscopic inguinal lymphadenectomy (VEIL)
- Experts in robotic video endoscopic inguinal lymphadenectomy (R-VEIL)
- Authors with at least one publication in ILND for penile cancer, vulvar cancer, or melanoma
Exclusion
- Panelists who were not able to commit to all rounds of the modified Delphi process will be excluded
Key Trial Info
Start Date :
June 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 15 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05388786
Start Date
June 1 2023
End Date
December 15 2024
Last Update
April 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Southern California
Los Angeles, California, United States, 90089